Peer Review reports
From: Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
| Original Submission | ||
|---|---|---|
| 2 Feb 2020 | Submitted | Original manuscript |
| 18 Feb 2020 | Reviewed | Reviewer Report - Yoshimitsu Akiyama |
| 21 Feb 2020 | Reviewed | Reviewer Report - Till Braunschweig |
| 24 Feb 2020 | Author responded | Author comments - Weide Zhong |
| 26 Feb 2020 | Reviewed | Reviewer Report - Till Braunschweig |
| 7 Mar 2020 | Reviewed | Reviewer Report - Yoshimitsu Akiyama |
| 16 Mar 2020 | Author responded | Author comments - Weide Zhong |
| Resubmission - Version 2 | ||
| 24 Feb 2020 | Submitted | Manuscript version 2 |
| Publishing | ||
| 23 Mar 2020 | Editorially accepted | |
| 6 Apr 2020 | Article published | 10.1186/s12885-020-06776-7 |
You can find further information about peer review here.